Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06135389

Population Pharmacokinetics of Paracetamol in Overweight and Obese Children

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The main objective of the study is to define population pharmacokinetic parameters and variability factors for paracetamol and its metabolites in overweight and obese children compared to children with normal weight for age and sex.

Detailed description

This study will determine the pharmacokinetic parameters of paracetamol and its metabolites in overweight and obese children compared to children with normal weight for age and sex. The results will enable establishing dosage recommendations for paracetamol in overweight and/or obese children and adolescents.

Conditions

Interventions

TypeNameDescription
BIOLOGICALTitration of paracetamol and its metabolites - scheme115 to 20 minutes and 1 to 2 hours after first perfusion and before second perfusion/administration of paracetamol
BIOLOGICALTitration of paracetamol and its metabolites - scheme 230 to 40' after first perfusion and before second perfusion/administration of paracetamol (residual concentration)

Timeline

Start date
2025-03-01
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2023-11-18
Last updated
2025-01-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06135389. Inclusion in this directory is not an endorsement.